EGFR and breast carcinoma: To date, it is most appropriate to define ER, PR, HER2, CK 5/6 and EGFR as the immunohistochemical markers for basal like subtype [8], which implied that triple negative was the main feature of basal like breast cancer for a lack of expression of ER, PR and HER2 by IHC.